Diagnosis of motor neuron disease Pille Taba, Karin Rallmann University of Tartu VI Nordic ALS Alliance Meeting Aug 21, 2010 Haapsalu, Estonia.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

The MS Clinic Alastair Lansbury Neurologist. What is MS ? Inflammatory Central Nervous System Autoimmune Relapses and remission (Progressive forms) Any.
Electrodiagnosis in the management and treatment of cervical and lumbar spine disorders Jonathan S. Rutchik, MD, MPH NEUROLOGY, ENVIRONMENTAL AND OCCUPATIONAL.
Amyotrophic lateral sclerosis (Lou Gehrig’s Disease)
Motor neuron disease What are motor neuron diseases? Who is at risk? What are the causes motor neuron diseases? How are they classified? What are the symptoms.
Acute Peripheral Weakness Peter Shearer, MD Assistant Residency Director Mt. Sinai School of Medicine.
Motor Neurone Disease Different types & Life Expectancy
ALS Kate Crain. Amyotrophic Lateral Sclerosis Lou Gehrig Disease Charcot’s Syndrome.
4 patients falling over. Mrs April Aged 62 Complains of tripping up when she walks on uneven surfaces Falls over and comes to hospital PMH COPD Vegan.
Neuromuscular disorders
Part I Mr. Robert Middelton … Over the past few years, he noticed...a slowly developing weakness initially in his hands and arms, now spreading to his.
Neurology Dr Chris Derry Consultant Neurologist
Amyotrophic Lateral Sclerosis (ALS) Sarah Belair and Hannah McLaughlin.
Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Introduction – Anna Conlan Role Regional Care Development Advisor (RCDA)
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
Lou Gehrig's Disease By: Brittany Harden.
Neurophysiological Basis of Movement World VI: Motor Disorders.
Amyotrophic lateral sclerosis (ALS). What is amyotrophic lateral sclerosis? It is a progressive neurological disease that affects the control of muscle.
PATRICK CASEY FALL 2007 PARAMEDIC CLASS Amyotrophic Lateral Sclerosis.
Initial presentation of multiple sclerosis in northern Iran; Is there any comparison to other countries Initial presentation of multiple sclerosis in northern.
SPINAL NERVE ROOT COMPRESSION AND PERIPHERAL NERVE DISORDERS Group A – AHD Dr. Gary Greenberg.
HTLV-1 Associated Myelopathy Diagnosis and Treatment
Amyotrophic Lateral Sclerosis
NORDIC ALS Alliance 2010& Baltic Bridge, Estonia Dr. M.S.I. Naudiņa Head of the Centre for Neuromuscular Diseases Pauls Stradins Clinical University.
Sagittal FLAIR images - Stable nonenhancing hyperintensities within the pericallosal white matter and bilateral centrum semiovale, consistent with known.
LOU GEHRIG’S DISEASE.  Also known as Amyotrophic Lateral Sclerosis  Is a disease of the nerve cells in the brain and spinal cord that control voluntary.
Anterior Horn Cell Disorders Shekhar J.Lamdhade Shekhar J.Lamdhade Consultant Neurologist Consultant Neurologist Al Amiri Hospital Al Amiri Hospital.
Adult Medical-Surgical Nursing Neurology Module: Multiple Sclerosis.
Motor neuron disease Dr.Shamekh M. El-Shamy.
Lou Gehrig’s Disease. - Jean-Martin Charcot discovered Men most affected - Still remains mostly a mystery.
Amyotrophic Lateral Sclerosis (ALS)
Guillain-Barre’ Syndrome
Out-patient Management in Neurology
Amyotrophic Lateral Sclerosis. Motor Neuron Disease Terminology Lower motor neuron Upper motor neuron Progressive Muscular Atrophy Amyotrophic Lateral.
Group A – AHD Dr. Gary Greenberg
Nervous System Diseases & Disorders Notes. Head Trauma #1 cause of trauma deaths in US Many possible mechanisms of injury: Falls Motor vehicle crashes.
漸凍症 amyotrophic lateral sclerosis. Lou Gehrig's disease 1939 Jean-Martin Charcot Amyotrophic lateral sclerosis (ALS) (Rosen DR et al. Nature 1993) 1869.
47-year-old with progressive upper limb weakness Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology.
Amyotrophic Lateral Sclerosis (ALS)
Patient #5 ALS. Patient Background and Problems Patient #5- Andrew, a 45 year-old single father of two, comes to you in confidence. He’s noticed that.
Neurology Department of Neurology, The 2nd affiliated hospital,
Electromyography Tatiana Steinwarz.
06/23/2002 RECENT ADVANCES IN TREATING POST-POLIO SYNDROME Susan L. Perlman, M.D. Associate Professor of Neurology UCLA Medical Center.
PATIENT #5: ANDREW Ashton Crowe Rayvin Ewers Miranda McCormick.
Amyotrophic Lateral Sclerosis (ALS)
ALS and Neuromuscular Diseases in Latvia Viktorija Ķēniņa M.D., Ph.D Neuroimmunologist at P. Stradins Clinical University Hospital.
Amyotrophic lateral sclerosis
Charcot-Marie- Tooth Disease Jessica Tzeng. History  Named after Jean-Martin Charcot, Pierre Marie (Charcot’s pupil), and Howard Henry Tooth  Not a.
Motor neuron disease.
T2 FLAIR Increased Signal Intensity at the Posterior Limb of the Internal Capsule: Clinical Significance in ALS Patients G. Protogerou 1, S. Ralli 2, I.
Amyotrophic Lateral Sclerosis (ALS). Also know as Lou Gehrig's Disease Named after the New York Yankees baseball star who played first base and was diagnosed.
Approach to the Patient with Weakness. What are clinical features that might lead you to believe that weakness is peripheral? Why is it important to localize.
Multiple Sclerosis. Multiple sclerosis (MS) is a disease that affects central nervous system (brain and spinal cord). It damages the myelin sheath. 
Frontotemporal Lobar Degeneration:
Diagnosing MND: what I say to patients and their families
Amyotrophic Lateral Sclerosis (ALS)
AMYOTROPHIC LATERAL SCLEROSIS
Motor Neurone Disease PROF MOHAMMAD ABDULJABBAR
Activity Communication Breakdown
Ashton Crowe Rayvin Ewers Miranda McCormick
Amyotrophic Lateral Sclerosis (ALS)
Muscle ultrasound as a diagnostic tool in
Amyotrophic Lateral Sclerosis
What does this protein make up or do? amyotrophic lateral sclerosis
Respiratory Management in MND
Ashton Crowe Rayvin Ewers Miranda McCormick
Respiratory Management in MND
Neurology Resident and Fellow Section
Presentation transcript:

Diagnosis of motor neuron disease Pille Taba, Karin Rallmann University of Tartu VI Nordic ALS Alliance Meeting Aug 21, 2010 Haapsalu, Estonia

Motor neuron disease (MND) Charcot J-M. Sclerose des cordons lateraux de la moelle epiniere … Bull Soc Med (Paris) 1865: − discussed clinic and pathology of a disorder that affected both upper and lower motor neuron Charcot disease Amyotrophic lateral sclerosis (ALS) Lou Gehrig disease (USA)

Motor pathway – upper and lower motor neuron

Motor neurons Levels Bulbar – speech, swallowing Cervical – upper limbs Thoracic - trunk Lumbar – lower limbs

Motor neuron disease Variants Graaff et al 2009

Motor neuron disease Epidemiology Incidence 1-3 cases per per year − In Estonia, incidence 1.3/ / year Prevalence 6-8 per Mostly sporadic Less than 10% familiar − About 20% of familiar ALS cases have SOD1 mutation (Cu/Zn superoxide dismutase enzyme) Burvill 2009 Gross-Paju et al 1998

Management of chronic disease Diagnosis Early/ delay Clinical signs Testing Information giving Disease modifying Symptomatic Psychosocial care Team approach

Diagnostic delay – why? Motor neuron disease – rare Variability of clinical picture Lack of diagnostic markers Delay of recognition of the disease by patient/ family or primary physician Time from the first symptoms to the confirmation of diagnosis – 14 months Murray et al 2004 Swash 1999

Theoretical timeline Motor function TIME Preclinical detectable genetically (?) Identifiable by imaging, molecular markers (?) Clinically overt disease Eisen 2009

Basis of diagnosis – history and clinical signs Dysarthria, dysphagia, paucity of tongue movements Muscle weakness and wasting Hand dysfunction Foot drop Fasciculations/ cramps Spastic gait Respiratory failure Progressive course

Diagnostic criteria World Federation of Neurology, Subcommittee on MND/ ALS - El Escorial Revisited Criteria (1998) Clinically definite ALS: upper and lower motor neuron signs in three regions Clinically probable ALS: upper and lower motor neuron signs in two regions Clinically probably laboratory supported ALS: upper and lower motor neuron dysfunction in one region + EMG Clinically possible ALS: dysfunction in one region Suspected ALS: only lower motor neuron signs Subcommittee on MND/ALS of WFN 1994; 1998

Symptoms to concern/ mimic syndromes Absence of fasciculations Sensory impairment Autonomic dysfunction Eye movement abnormalities Sphincter impairment Movement disorders Cognitive impairment (Alzheimer type) Symmetrical lower motor neuron signs Mitchell 2007

Incorrect diagnosis (initial diagnosis) Cervical myelopathy Multifocal motor neuropathy Multiple sclerosis (primary progressive) Radiculpathy (painless) Chronic inflammatory demyelinating polyneuropathy Myositis Cerebrovascular disease Periarthritis Eisen 2009 Gross-Paju et al 1998

Differential diagnosis of ALS Muscle diseases Diseases of neuromuscular junction Diseases of anterior horn cells Diseases of spinal cord Diseases of central nervous system Systemic disorders

Differential diagnosis To exclude other causes of a slowly progressive spastic paraparesis − Cervical disc − Hereditary spastic paraplegia − … Investigation − Imaging: MRI – cervical, bulbar − EMG

Confirming the diagnosis of MND/ ALS Investigations: electroneuromyography

Investigations: imaging MRI – magnetic resonance imaging DTI – diffusion tensor imaging of the cortical spinal tract MR spectroscopy − N-acetyl aspartate (NAA), marker for upper motor neuron degeneration − myo-inositol (MI), marker for glial activity MRI T2-weighted (FLAIR) Graaff et al 2009

Investigations: laboratory sampling No specific biomarkers for confirming ALS For excluding different pathology − Metabolic studies: blood chemistry − Endocrinologic studies: thyroid function etc − Screening monoclonal gammopathy: viruses − CSF: exclude inflammatory processes

Functional scales – measuring change in status ALSFRS – ALS Functional Rating Scale − To assess the more important activities − Complete reliability and validity testing Norris Scale Appel Scale − Additionally history − Uses manual muscle testing (MMT) Tufts Quantitative Neuromuscular Exam − Maximal voluntary isometric contraction − Repetitive functional test Munsat 1996

Swash 1999

Neurologist Family doctor Psychologist Speech therapist Occupational therapist Physiotherapist Nurse Radiologist Social worker Dietician Rehabilitation doctor Family Carer Patient Neurophysiologist